ESMO open
Corrigendum to "A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)": [ESMO Open. Volume 10, Issue 9, (September 2025) 105571].
M Wakabayashi, H Taniguchi, A Makiyama, Y Sunakawa, H Takeda, K Arimizu, Y Okumura, C Inagaki, S Mitani, T Kudo, S Yuki, N Akazawa, C Kudo, K Mori, T Matsuda
Published: 202610.1016/j.esmoop.2025.105912
No abstract available for this study.